Tagne Nouemssi Alain Bruno
Department of Family Medicine, NYMC Saint Joseph Hospital Family Medicine Residency program, New York, USA.
BMJ Case Rep. 2018 Apr 21;2018:bcr-2017-221771. doi: 10.1136/bcr-2017-221771.
Risperidone and paliperidone palmitate are two antipsychotic drugs well tolerated in the management of schizophrenia and other psychiatric conditions. There have been few reports of tachycardia induced by either drugs. Here, we report on a 21-year-old man, with a history of schizophrenia, and who developed persistent sinus tachycardia after he was restarted on risperidone, which later worsened after administration of paliperidone palmitate for long-term management. He had no cardiovascular risk factors other than obesity, and a prior well-tolerated risperidone treatment. Clinicians must be aware of the possibility of patients developing sinus tachycardia due to autonomic instability from a prior risperidone treatment, even though overall, these drugs are well tolerated.
利培酮和棕榈酸帕利哌酮是两种在治疗精神分裂症和其他精神疾病时耐受性良好的抗精神病药物。关于这两种药物诱发心动过速的报道很少。在此,我们报告一名21岁有精神分裂症病史的男性,他在重新开始使用利培酮后出现持续性窦性心动过速,在使用棕榈酸帕利哌酮进行长期治疗后病情加重。除肥胖外,他没有心血管危险因素,且之前使用利培酮治疗时耐受性良好。临床医生必须意识到,尽管总体而言这些药物耐受性良好,但患者可能因之前使用利培酮治疗导致自主神经不稳定而出现窦性心动过速。